KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biolife Solutions (BLFS) Cash from Investing Activities (2016 - 2025)

Biolife Solutions (BLFS) has disclosed Cash from Investing Activities for 16 consecutive years, with $1.1 million as the latest value for Q4 2025.

  • On a quarterly basis, Cash from Investing Activities fell 98.46% to $1.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$71.5 million, a 222.71% decrease, with the full-year FY2025 number at -$71.5 million, down 222.71% from a year prior.
  • Cash from Investing Activities was $1.1 million for Q4 2025 at Biolife Solutions, up from -$6.0 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $73.6 million in Q4 2024 to a low of -$39.5 million in Q2 2025.
  • A 5-year average of -$3.3 million and a median of -$2.4 million in 2021 define the central range for Cash from Investing Activities.
  • Peak YoY movement for Cash from Investing Activities: soared 1760.93% in 2024, then crashed 12196.83% in 2025.
  • Biolife Solutions' Cash from Investing Activities stood at -$2.5 million in 2021, then plummeted by 485.92% to -$14.9 million in 2022, then soared by 126.57% to $4.0 million in 2023, then skyrocketed by 1760.93% to $73.6 million in 2024, then plummeted by 98.46% to $1.1 million in 2025.
  • Per Business Quant, the three most recent readings for BLFS's Cash from Investing Activities are $1.1 million (Q4 2025), -$6.0 million (Q3 2025), and -$39.5 million (Q2 2025).